[
    [
        {
            "time": "",
            "original_text": "海南自贸港迎重磅利好，国产新冠疫苗明年产能将达50亿剂丨明日主题前瞻",
            "features": {
                "keywords": [
                    "海南自贸港",
                    "新冠疫苗",
                    "产能",
                    "50亿剂"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "海南自贸港迎重磅利好，国产新冠疫苗明年产能将达50亿剂丨明日主题前瞻",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国内疫苗接种提速，明年产能将达50亿剂，行业或迎放量密集期",
            "features": {
                "keywords": [
                    "疫苗接种",
                    "提速",
                    "产能",
                    "放量密集期"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内疫苗接种提速，明年产能将达50亿剂，行业或迎放量密集期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业2021年一季度疫苗行业批签发专题报告：大品种批签发快速增长 行业高景气度持续",
            "features": {
                "keywords": [
                    "医药行业",
                    "批签发",
                    "大品种",
                    "高景气度"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2021年一季度疫苗行业批签发专题报告：大品种批签发快速增长 行业高景气度持续",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "疫苗股整体强势，辽宁成大、康泰生物、万泰生物均涨超5%",
            "features": {
                "keywords": [
                    "疫苗股",
                    "辽宁成大",
                    "康泰生物",
                    "万泰生物",
                    "涨超5%"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗股整体强势，辽宁成大、康泰生物、万泰生物均涨超5%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "A股异动 | 康泰生物(300601.SZ)涨近5% P3生物安全生产车间已完成建设并通过国家生物安全认证",
            "features": {
                "keywords": [
                    "A股",
                    "康泰生物",
                    "P3生物安全",
                    "生产车间",
                    "国家生物安全认证"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股异动 | 康泰生物(300601.SZ)涨近5% P3生物安全生产车间已完成建设并通过国家生物安全认证",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：医疗体系运行常态化 看好一季度业绩表现",
            "features": {
                "keywords": [
                    "医药生物行业",
                    "医疗体系",
                    "常态化",
                    "一季度业绩"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：医疗体系运行常态化 看好一季度业绩表现",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]